Express Scripts Earns $1.88 per Share

After the bell on Tuesday, Express Scripts (ESRX) reported Q4 earnings of $1.88 per share. That beat estimates by one penny per share. For the year, Express earned $6.39 per share, which is a nice 16% increase over 2015. Earlier, Express had said that its full-year total would range between $6.36 and $6.42 per share. Overall, this was a solid year for the company.

“We delivered another year of successful performance, not only through financial results, but by providing innovative solutions to help our patients and clients drive healthier outcomes and lower drug trends,” said Tim Wentworth, CEO and President. “In a year when the focus on drug pricing has never been greater, Express Scripts has held the 2016 growth rate in drug unit costs to 2.5% and lowered the patients’ share of total drug costs per prescription. The fundamentals of our business remain strong as our clinical focus and unwavering alignment with clients enables us to lead the industry in developing innovative value-based solutions that our country needs.”

Quarterly revenue came in at $24.86 billion, which was below estimates. For Q1, Express said it expects earnings between $1.30 and $1.34 per share. The Street had been expecting $1.35 per share. For the whole year, they see EPS ranging between $6.82 and $7.02 per share. That means the stock is going for about 10 times this year’s earnings. The shares are down about 1% in the after-hours market.

Posted by on February 14th, 2017 at 6:30 pm

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.